If approved, it would be the first major new drug treatment for Parkinson’s in half a century. Richard Mailman, a University ...

Glovadalen, a novel D1 receptor positive allosteric modulator, is linked to improve OFF time in patients with Parkinson’s ...

Drugs commonly prescribed to treat Parkinson's disease have been linked to impulse control disorders such as pathological gambling, compulsive buying, hypersexuality and binge eating in some patients, ...

Australian-founded medical technology company SYMBYX today announced compelling results from a 72-week randomized controlled ...

For example: Missed or delayed Parkinson's medications during a hospital stay may lead to increased fall risk, difficulty participating in rehabilitation or delayed discharge. Swallowing problems ...

A novel biodegradable gel delivers Parkinson’s medications via a single weekly shot, potentially replacing current regimens of multiple pills per day. The corresponding study was published in Drug ...

Commonly prescribed medications such as statins, non-steroidal anti-inflammatory drugs and certain blood pressure drugs may significantly delay the onset of Parkinson’s disease. The study, published ...

"I remember my right hand being able to move with much more ease once the stimulation was applied, and this in turn improved ...

Parkinson’s patients taking antipsychotic medications have a significant increased risk of death, according to a new study published in JAMA Neurology and covered by News Medical. For the study, ...

Skin conditions with Parkinson’s disease are common and manageable. By paying attention to these symptoms, patients can ...

Researchers have devised a new way to illuminate the previously invisible oligomer clumps driving Parkinson’s disease.

Meanwhile, beta blocker medications tend to reduce REM sleep, which is when most dreaming occurs, but research has found that ...